FI20095355A0 - Regeneroituva aktiivinen matriisi ja sen käytöt - Google Patents

Regeneroituva aktiivinen matriisi ja sen käytöt

Info

Publication number
FI20095355A0
FI20095355A0 FI20095355A FI20095355A FI20095355A0 FI 20095355 A0 FI20095355 A0 FI 20095355A0 FI 20095355 A FI20095355 A FI 20095355A FI 20095355 A FI20095355 A FI 20095355A FI 20095355 A0 FI20095355 A0 FI 20095355A0
Authority
FI
Finland
Prior art keywords
active matrix
regenerative active
regenerative
matrix
active
Prior art date
Application number
FI20095355A
Other languages
English (en)
Swedish (sv)
Inventor
Jozef Bizik
Ari Harjula
Esko Kankuri
Original Assignee
Helsingin Yliopisto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsingin Yliopisto filed Critical Helsingin Yliopisto
Priority to FI20095355A priority Critical patent/FI20095355A0/fi
Publication of FI20095355A0 publication Critical patent/FI20095355A0/fi
Priority to PCT/FI2010/050256 priority patent/WO2010112678A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/0005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Surgery (AREA)
  • Reproductive Health (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FI20095355A 2009-04-01 2009-04-01 Regeneroituva aktiivinen matriisi ja sen käytöt FI20095355A0 (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI20095355A FI20095355A0 (fi) 2009-04-01 2009-04-01 Regeneroituva aktiivinen matriisi ja sen käytöt
PCT/FI2010/050256 WO2010112678A1 (en) 2009-04-01 2010-03-31 Regenerative matrix comprising cells activated by nemosis and/or factors released from such cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20095355A FI20095355A0 (fi) 2009-04-01 2009-04-01 Regeneroituva aktiivinen matriisi ja sen käytöt

Publications (1)

Publication Number Publication Date
FI20095355A0 true FI20095355A0 (fi) 2009-04-01

Family

ID=40590238

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20095355A FI20095355A0 (fi) 2009-04-01 2009-04-01 Regeneroituva aktiivinen matriisi ja sen käytöt

Country Status (2)

Country Link
FI (1) FI20095355A0 (fi)
WO (1) WO2010112678A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3200843A4 (en) * 2014-10-03 2018-06-20 Cytori Therapeutics, Inc. Use of regenerative cells in mitigating burn progression and improving skin graft incorporation and healing
US10926001B2 (en) 2014-12-02 2021-02-23 Polarityte, Inc. Methods related to minimally polarized functional units
FR3082123B1 (fr) * 2018-06-07 2020-10-16 Urgo Rech Innovation Et Developpement Pansement cellularise et son procede de fabrication
EP4410320A1 (en) * 2023-02-06 2024-08-07 FibroBiologics, Inc. Reuse of fibroblasts for skin augmentation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992009301A1 (en) * 1990-11-27 1992-06-11 The American National Red Cross Tissue sealant and growth factor containing compositions that promote accelerated wound healing
US6372494B1 (en) * 1999-05-14 2002-04-16 Advanced Tissue Sciences, Inc. Methods of making conditioned cell culture medium compositions
US7144729B2 (en) * 2000-09-01 2006-12-05 Dfb Pharmaceuticals, Inc. Methods and compositions for tissue regeneration
US7993922B2 (en) * 2002-10-18 2011-08-09 Reliance Life Sciences Pvt. Ltd. Three-dimensional tissue equivalent using macromass culture
CN101379182A (zh) * 2005-12-14 2009-03-04 器官发生有限公司 皮肤护理组合物以及处理
RU2342164C2 (ru) * 2006-04-03 2008-12-27 Общество с ограниченной ответственностью "Центр клеточных технологий" Эквивалент кожи и способ его получения
FI20065514A0 (fi) * 2006-08-16 2006-08-16 Licentia Oy Aktivoidut fibroblastit kudosvaurioiden hoitamiseksi

Also Published As

Publication number Publication date
WO2010112678A1 (en) 2010-10-07

Similar Documents

Publication Publication Date Title
BRPI0922486A2 (pt) microcápsulas e suas respectivas utilizações
BRPI0907231A2 (pt) pirrolpirimidinas e pirrolpiridinas
FI20100257A (fi) Menetelmä ja hissijärjestely
BRPI0914175A2 (pt) Estruturas absorventes com material absorvente imobilizado
BRPI1010079A2 (pt) composição e artigo
BRPI0911118A2 (pt) composto e compisições como moduladores de atividade de gpr119
ATE522136T1 (de) Wirkstoffsuspensionen in glycerin
BRPI0912201A2 (pt) células formadoras de colônias de hemangios e células de hemangio não enxertantes
BR112012002247A2 (pt) composição e artigo
DK3783103T3 (da) Amylasepolypeptider
DK2338529T3 (da) Hydrogelmatrix med forbedrede klæbeegenskaber
DK2379995T3 (da) Vejecelle
BRPI0924451A2 (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
BRPI0920502A2 (pt) compostos cicloundecadepsipeptídeos e seu uso como medicamento
BRPI0915444A2 (pt) dispositivo de display, método para fabricar o mesmo, e substrato de matriz ativa
BRPI0924436A2 (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
FI20095355A0 (fi) Regeneroituva aktiivinen matriisi ja sen käytöt
BR112013013582A2 (pt) matriz de dobramento
BRPI0915704A2 (pt) microorganismo expressando aldose-1-epimerase
BRPI0918169A2 (pt) entretela com células distanciadoras
FI20095842A0 (fi) Trukkihaarukan varsi ja trukkihaarukka
BRPI1010251A2 (pt) utilização de fibrinogênio e composição farmacêutica
DK2310037T3 (da) Conglutin-gamma as-medikament og -kosttilskudpatentkrav
FR2969172B1 (fr) Nouvelles souches de levure de panification
BRPI0915505A8 (pt) tratamento de mensagens

Legal Events

Date Code Title Description
FD Application lapsed